Glaucoma

While there are many causes of glaucoma, most cases are associated with increased intraocular pressure. Loss of vision is usually characterized by a gradual reduction in peripheral vision, which can lead to a tunnel vision effect. Glaucoma affects approximately 100 million people globally and is one of the leading causes of blindness in the world today. An estimated three million Americans have this sight-threatening disease. Because it is painless and advances gradually, many people who have glaucoma or elevated IOP have not been diagnosed. If detected and treated early, vision can usually be preserved.
What is Glaucoma?

Glaucoma is a common ocular condition whereby damage is caused to the optic nerve connecting the eye to the brain.

Read More

Overview

Feature Articles

Latest Glaucoma News and Research

Glaucoma treatment using smart contact lenses that release drugs

Glaucoma treatment using smart contact lenses that release drugs

Ocular toxoplasmosis found to be common among Australians

Ocular toxoplasmosis found to be common among Australians

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

Medical Experts and Social Media; Healthcare Education Through a New Lens

Medical Experts and Social Media; Healthcare Education Through a New Lens

New study paves the way for first drug treatment for sleep apnea

New study paves the way for first drug treatment for sleep apnea

Childhood glaucoma poses significant threat to caregiver’s quality of life

Childhood glaucoma poses significant threat to caregiver’s quality of life

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

Mechanism behind how certain osmolytes cause kidney damage revealed

Mechanism behind how certain osmolytes cause kidney damage revealed

Cognitive impairment in patients with long-COVID can be improved using brain stimulation

Cognitive impairment in patients with long-COVID can be improved using brain stimulation

New study offers valuable information on ocular drug metabolism and pharmacokinetics

New study offers valuable information on ocular drug metabolism and pharmacokinetics

Medical marijuana users brace for shortages as Montana’s recreational market opens

Medical marijuana users brace for shortages as Montana’s recreational market opens

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Ophthalmology professor receives $75,000 grant to support international collaborations on eye research

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Infantile cataracts are more common and problematic than thought

Infantile cataracts are more common and problematic than thought

Cataract surgery associated with lower risk of dementia

Cataract surgery associated with lower risk of dementia

NEI researchers identify unique population of B cells that tamps down the immune system

NEI researchers identify unique population of B cells that tamps down the immune system

Stranded by the pandemic, he had only travel insurance. It left him with a $38,000 bill.

Stranded by the pandemic, he had only travel insurance. It left him with a $38,000 bill.

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

New project investigates stem cell therapy as a potential treatment for glaucoma

New project investigates stem cell therapy as a potential treatment for glaucoma

Laser treatment shows potential to transform glaucoma management in Africa

Laser treatment shows potential to transform glaucoma management in Africa